Ovid Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell OVID and other ETFs, options, and stocks.About OVID
Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During on April 1, 2014 and is headquartered in New York, NY.
OVID Key Statistics
Stock Snapshot
The current Ovid Therapeutics(OVID) stock price is $1.62, with a market capitalization of 115.72M. The stock trades at a price-to-earnings (P/E) ratio of -3.19.
On 2025-11-27, Ovid Therapeutics(OVID) stock moved within a range of $1.50 to $1.66. With shares now at $1.62, the stock is trading +7.7% above its intraday low and -2.7% below the session's peak.
Trading volume for Ovid Therapeutics(OVID) stock has reached 3.22M, versus its average volume of 1.68M.
Over the past 52 weeks, Ovid Therapeutics(OVID) stock has traded between a high of $2.01 and a low of $0.24.
Over the past 52 weeks, Ovid Therapeutics(OVID) stock has traded between a high of $2.01 and a low of $0.24.
OVID News
As the U.S. stock market enjoys a promising streak with major indexes on track for their best week since June, investors are eyeing opportunities across various...